{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:57:37Z","timestamp":1790290657590,"version":"4.1.0"},"publisher-location":"Cham","reference-count":167,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030336783","type":"print"},{"value":"9783030336790","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/164_2019_260","type":"book-chapter","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T10:33:22Z","timestamp":1589884402000},"page":"463-502","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Newly Emerging Drugs of Abuse"],"prefix":"10.1007","author":[{"given":"Kenichi","family":"Tamama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,9]]},"reference":[{"key":"260_CR1","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1021\/acs.jnatprod.5b00949","volume":"79","author":"O Aizpurua-Olaizola","year":"2016","unstructured":"Aizpurua-Olaizola O, Soydaner U, Ozturk E, Schibano D, Simsir Y, Navarro P, Etxebarria N, Usobiaga A (2016) Evolution of the cannabinoid and terpene content during the growth of cannabis sativa plants from different chemotypes. J Nat Prod 79:324\u2013331. \nhttps:\/\/doi.org\/10.1021\/acs.jnatprod.5b00949","journal-title":"J Nat Prod"},{"key":"260_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fpls.2016.00019","volume":"7","author":"CM Andre","year":"2016","unstructured":"Andre CM, Hausman JF, Guerriero G (2016) Cannabis sativa: the plant of the thousand and one molecules. Front Plant Sci 7:19. \nhttps:\/\/doi.org\/10.3389\/fpls.2016.00019","journal-title":"Front Plant Sci"},{"key":"260_CR3","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.drugalcdep.2011.10.007","volume":"122","author":"MD Arbo","year":"2012","unstructured":"Arbo MD, Bastos ML, Carmo HF (2012) Piperazine compounds as drugs of abuse. Drug Alcohol Depend 122:174\u2013185. \nhttps:\/\/doi.org\/10.1016\/j.drugalcdep.2011.10.007","journal-title":"Drug Alcohol Depend"},{"key":"260_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.neuropharm.2017.10.016","volume":"134","author":"P Armenian","year":"2018","unstructured":"Armenian P, Vo KT, Barr-Walker J, Lynch KL (2018) Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review. Neuropharmacology 134:121\u2013132. \nhttps:\/\/doi.org\/10.1016\/j.neuropharm.2017.10.016","journal-title":"Neuropharmacology"},{"key":"260_CR5","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/jat\/bkt024","volume":"37","author":"A Arntson","year":"2013","unstructured":"Arntson A, Ofsa B, Lancaster D, Simon JR, McMullin M, Logan B (2013) Validation of a novel immunoassay for the detection of synthetic cannabinoids and metabolites in urine specimens. J Anal Toxicol 37:284\u2013290. \nhttps:\/\/doi.org\/10.1093\/jat\/bkt024","journal-title":"J Anal Toxicol"},{"key":"260_CR6","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/jms.1558","volume":"44","author":"V Auwarter","year":"2009","unstructured":"Auwarter V, Dresen S, Weinmann W, Muller M, Putz M, Ferreiros N (2009) \u2018Spice\u2019 and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom 44:832\u2013837. \nhttps:\/\/doi.org\/10.1002\/jms.1558","journal-title":"J Mass Spectrom"},{"key":"260_CR7","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1007\/s00204-018-2244-6","volume":"92","author":"BA Baldo","year":"2018","unstructured":"Baldo BA (2018) Opioid analgesic drugs and serotonin toxicity (syndrome): mechanisms, animal models, and links to clinical effects. Arch Toxicol 92:2457\u20132473. \nhttps:\/\/doi.org\/10.1007\/s00204-018-2244-6","journal-title":"Arch Toxicol"},{"key":"260_CR8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1159\/000492616","volume":"27","author":"M Behzadi","year":"2018","unstructured":"Behzadi M, Joukar S, Beik A (2018) Opioids and cardiac arrhythmia: a literature review. Med Princ Pract 27:401\u2013414. \nhttps:\/\/doi.org\/10.1159\/000492616","journal-title":"Med Princ Pract"},{"key":"260_CR9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2165\/11536200-000000000-00000","volume":"49","author":"HN Bockbrader","year":"2010","unstructured":"Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek N, Burger P (2010) A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet 49:661\u2013669. \nhttps:\/\/doi.org\/10.2165\/11536200-000000000-00000","journal-title":"Clin Pharmacokinet"},{"key":"260_CR10","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/npp.2017.209","volume":"43","author":"DL Boggs","year":"2018","unstructured":"Boggs DL, Nguyen JD, Morgenson D, Taffe MA, Ranganathan M (2018) Clinical and preclinical evidence for functional interactions of cannabidiol and delta(9)-tetrahydrocannabinol. Neuropsychopharmacology 43:142\u2013154. \nhttps:\/\/doi.org\/10.1038\/npp.2017.209","journal-title":"Neuropsychopharmacology"},{"key":"260_CR11","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1001\/jama.2017.11909","volume":"318","author":"MO Bonn-Miller","year":"2017","unstructured":"Bonn-Miller MO, Loflin MJE, Thomas BF, Marcu JP, Hyke T, Vandrey R (2017) Labeling accuracy of cannabidiol extracts sold online. JAMA 318:1708\u20131709. \nhttps:\/\/doi.org\/10.1001\/jama.2017.11909","journal-title":"JAMA"},{"key":"260_CR12","doi-asserted-by":"publisher","first-page":"5994","DOI":"10.2174\/138161212803582469","volume":"18","author":"M Boom","year":"2012","unstructured":"Boom M, Niesters M, Sarton E, Aarts L, Smith TW, Dahan A (2012) Non-analgesic effects of opioids: opioid-induced respiratory depression. Curr Pharm Des 18:5994\u20136004","journal-title":"Curr Pharm Des"},{"key":"260_CR13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJMra1202561","volume":"367","author":"EW Boyer","year":"2012","unstructured":"Boyer EW (2012) Management of opioid analgesic overdose. N Engl J Med 367:146\u2013155. \nhttps:\/\/doi.org\/10.1056\/NEJMra1202561","journal-title":"N Engl J Med"},{"key":"260_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3389\/fphar.2017.00108","volume":"8","author":"EJ Brand","year":"2017","unstructured":"Brand EJ, Zhao Z (2017) Cannabis in chinese medicine: are some traditional indications referenced in ancient literature related to cannabinoids? Front Pharmacol 8:108. \nhttps:\/\/doi.org\/10.3389\/fphar.2017.00108","journal-title":"Front Pharmacol"},{"key":"260_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3109\/03602532.2013.839700","volume":"46","author":"LK Brents","year":"2014","unstructured":"Brents LK, Prather PL (2014) The K2\/spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products. Drug Metab Rev 46:72\u201385. \nhttps:\/\/doi.org\/10.3109\/03602532.2013.839700","journal-title":"Drug Metab Rev"},{"key":"260_CR16","first-page":"158P","volume":"49","author":"RT Brittain","year":"1973","unstructured":"Brittain RT, Kellett DN, Neat ML, Stables R (1973) Proceedings: anti-nociceptive effects in N-substituted cyclohexylmethylbenzamides. Br J Pharmacol 49:158P\u2013159P","journal-title":"Br J Pharmacol"},{"key":"260_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.forsciint.2016.02.033","volume":"262","author":"J Broseus","year":"2016","unstructured":"Broseus J, Gentile N, Esseiva P (2016) The cutting of cocaine and heroin: a critical review. Forensic Sci Int 262:73\u201383. \nhttps:\/\/doi.org\/10.1016\/j.forsciint.2016.02.033","journal-title":"Forensic Sci Int"},{"issue":"4","key":"260_CR18","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/15563650.2018.1510502","volume":"57","author":"JE Carpenter","year":"2018","unstructured":"Carpenter JE, Murray BP, Dunkley C, Kazzi ZN, Gittinger MH (2018) Designer benzodiazepines: a report of exposures recorded in the National Poison Data System, 2014\u20132017. Clin Toxicol (Phila) 57(4):282\u2013286. \nhttps:\/\/doi.org\/10.1080\/15563650.2018.1510502","journal-title":"Clin Toxicol (Phila)"},{"key":"260_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.drugalcdep.2014.08.005","volume":"144","author":"MS Castaneto","year":"2014","unstructured":"Castaneto MS, Gorelick DA, Desrosiers NA, Hartman RL, Pirard S, Huestis MA (2014) Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend 144:12\u201341. \nhttps:\/\/doi.org\/10.1016\/j.drugalcdep.2014.08.005","journal-title":"Drug Alcohol Depend"},{"key":"260_CR20","unstructured":"Cayman Chemical Standardized Naming of Substituted Fentanyls. \nhttps:\/\/www.caymanchem.com\/Literature\/standardized-naming-of-substituted-fentanyls\n\n. Accessed 4 Dec 2018"},{"key":"260_CR21","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/dta.1590","volume":"6","author":"P Chen","year":"2014","unstructured":"Chen P, Braithwaite RA, George C, Hylands PJ, Parkin MC, Smith NW, Kicman AT (2014) The poppy seed defense: a novel solution. Drug Test Anal 6:194\u2013201. \nhttps:\/\/doi.org\/10.1002\/dta.1590","journal-title":"Drug Test Anal"},{"key":"260_CR22","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/jps.2600530602","volume":"53","author":"SJ Childress","year":"1964","unstructured":"Childress SJ, Gluckman MI (1964) 1,4-Benzodiazepines. J Pharm Sci 53:577\u2013590","journal-title":"J Pharm Sci"},{"key":"260_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/hup.1242","volume":"27","author":"O Corazza","year":"2012","unstructured":"Corazza O, Schifano F, Simonato P, Fergus S, Assi S, Stair J, Corkery J, Trincas G, Deluca P, Davey Z, Blaszko U, Demetrovics Z, Moskalewicz J, Enea A, di Melchiorre G, Mervo B, di Furia L, Farre M, Flesland L, Pasinetti M, Pezzolesi C, Pisarska A, Shapiro H, Siemann H, Skutle A, Enea A, di Melchiorre G, Sferrazza E, Torrens M, van der Kreeft P, Zummo D, Scherbaum N (2012) Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine. Hum Psychopharmacol 27:145\u2013149. \nhttps:\/\/doi.org\/10.1002\/hup.1242","journal-title":"Hum Psychopharmacol"},{"key":"260_CR24","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/cns.12063","volume":"19","author":"O Corazza","year":"2013","unstructured":"Corazza O, Assi S, Schifano F (2013) From \u201cSpecial K\u201d to \u201cSpecial M\u201d: the evolution of the recreational use of ketamine and methoxetamine. CNS Neurosci Ther 19:454\u2013460. \nhttps:\/\/doi.org\/10.1111\/cns.12063","journal-title":"CNS Neurosci Ther"},{"key":"260_CR25","doi-asserted-by":"publisher","first-page":"904","DOI":"10.15585\/mmwr.mm6634a3","volume":"66","author":"R Daniulaityte","year":"2017","unstructured":"Daniulaityte R, Juhascik MP, Strayer KE, Sizemore IE, Harshbarger KE, Antonides HM, Carlson RR (2017) Overdose deaths related to fentanyl and its analogs \u2013 Ohio, January-February 2017. MMWR Morb Mortal Wkly Rep 66:904\u2013908. \nhttps:\/\/doi.org\/10.15585\/mmwr.mm6634a3","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"260_CR26","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1021\/acschemneuro.8b00150","volume":"9","author":"AL Devereaux","year":"2018","unstructured":"Devereaux AL, Mercer SL, Cunningham CW (2018) DARK classics in chemical neuroscience: morphine. ACS Chem Neurosci 9:2395\u20132407. \nhttps:\/\/doi.org\/10.1021\/acschemneuro.8b00150","journal-title":"ACS Chem Neurosci"},{"key":"260_CR27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1080\/03602532.2016.1278228","volume":"49","author":"RJ Dinis-Oliveira","year":"2017","unstructured":"Dinis-Oliveira RJ (2017) Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance. Drug Metab Rev 49:84\u201391. \nhttps:\/\/doi.org\/10.1080\/03602532.2016.1278228","journal-title":"Drug Metab Rev"},{"key":"260_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.brainresbull.2016.03.002","volume":"126","author":"E Dominguez-Clave","year":"2016","unstructured":"Dominguez-Clave E, Soler J, Elices M, Pascual JC, Alvarez E, de la Fuente RM, Friedlander P, Feilding A, Riba J (2016) Ayahuasca: pharmacology, neuroscience and therapeutic potential. Brain Res Bull 126:89\u2013101. \nhttps:\/\/doi.org\/10.1016\/j.brainresbull.2016.03.002","journal-title":"Brain Res Bull"},{"key":"260_CR29","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1213\/ane.0b013e31817c737d","volume":"107","author":"EF Domino","year":"2008","unstructured":"Domino EF (2008) Dr. Paul: views through the piperidine ring. Anesth Analg 107:723\u2013724; author reply 724. \nhttps:\/\/doi.org\/10.1213\/ane.0b013e31817c737d","journal-title":"Anesth Analg"},{"key":"260_CR30","first-page":"189","volume":"2","author":"HW Dove","year":"1984","unstructured":"Dove HW (1984) Phencyclidine: pharmacologic and clinical review. Psychiatr Med 2:189\u2013209","journal-title":"Psychiatr Med"},{"key":"260_CR31","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3109\/15563650.2015.1059945","volume":"53","author":"MA Downes","year":"2015","unstructured":"Downes MA, Berling IL, Mostafa A, Grice J, Roberts MS, Isbister GK (2015) Acute behavioural disturbance associated with phenibut purchased via an internet supplier. Clin Toxicol (Phila) 53:636\u2013638. \nhttps:\/\/doi.org\/10.3109\/15563650.2015.1059945","journal-title":"Clin Toxicol (Phila)"},{"key":"260_CR32","unstructured":"Drug Enforcement Administration (DEA) (2017) 2017 National drug threat assessment. In: U.S. Department of Justice (ed)"},{"key":"260_CR33","unstructured":"Drug Enforcement Administration (DEA) (2018a) 2018 National drug threat assessment. In: U.S. Department of Justice (ed)"},{"key":"260_CR34","unstructured":"Drug Enforcement Administration (DEA) (2018b) Emerging threat report, annual 2017. In: U.S. Department of Justice (ed)"},{"key":"260_CR35","unstructured":"Drug Enforcement Administration (DEA) (2018c) Emerging threat report, mid-year 2018. In: U.S. Department of Justice (ed)"},{"key":"260_CR36","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.biopsych.2016.01.004","volume":"79","author":"MA ElSohly","year":"2016","unstructured":"ElSohly MA, Mehmedic Z, Foster S, Gon C, Chandra S, Church JC (2016) Changes in cannabis potency over the last 2 decades (1995-2014): analysis of current data in the United States. Biol Psychiatry 79:613\u2013619. \nhttps:\/\/doi.org\/10.1016\/j.biopsych.2016.01.004","journal-title":"Biol Psychiatry"},{"key":"260_CR37","volume-title":"Understanding the \u2018Spice\u2019 phenomenon","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2009","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (2009) Understanding the \u2018Spice\u2019 phenomenon. Publications Office of the European Union, Luxembourg"},{"key":"260_CR38","volume-title":"Fentanils and synthetic cannabinoids: driving greater complexity into the drug situation. An update from the EU Early Warning System","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2018","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (2018) Fentanils and synthetic cannabinoids: driving greater complexity into the drug situation. An update from the EU Early Warning System. Publications Office of the European Union, Luxembourg"},{"key":"260_CR39","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1097\/MLR.0000000000000625","volume":"54","author":"CS Florence","year":"2016","unstructured":"Florence CS, Zhou C, Luo F, Xu L (2016) The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013. Med Care 54:901\u2013906. \nhttps:\/\/doi.org\/10.1097\/MLR.0000000000000625","journal-title":"Med Care"},{"key":"260_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.2174\/1874473710666170712113042","volume":"10","author":"TC Ford","year":"2017","unstructured":"Ford TC, Hayley AC, Downey LA, Parrott AC (2017) Cannabis: an overview of its adverse acute and chronic effects and its implications. Curr Drug Abuse Rev 10:6\u201318. \nhttps:\/\/doi.org\/10.2174\/1874473710666170712113042","journal-title":"Curr Drug Abuse Rev"},{"key":"260_CR41","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neuro.2018.11.004","volume":"70","author":"MB Gatch","year":"2018","unstructured":"Gatch MB, Forster MJ (2018) Cannabinoid-like effects of five novel carboxamide synthetic cannabinoids. Neurotoxicology 70:72\u201379. \nhttps:\/\/doi.org\/10.1016\/j.neuro.2018.11.004","journal-title":"Neurotoxicology"},{"key":"260_CR42","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1124\/pr.114.008979","volume":"68","author":"L Gendron","year":"2016","unstructured":"Gendron L, Cahill CM, von Zastrow M, Schiller PW, Pineyro G (2016) Molecular pharmacology of delta-opioid receptors. Pharmacol Rev 68:631\u2013700. \nhttps:\/\/doi.org\/10.1124\/pr.114.008979","journal-title":"Pharmacol Rev"},{"key":"260_CR43","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1373\/clinchem.2017.275164","volume":"63","author":"JR Genzen","year":"2017","unstructured":"Genzen JR, Mohlman JS, Lynch JL, Squires MW, Weiss RL (2017) Laboratory-developed tests: a legislative and regulatory review. Clin Chem 63:1575\u20131584. \nhttps:\/\/doi.org\/10.1373\/clinchem.2017.275164","journal-title":"Clin Chem"},{"key":"260_CR44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jchromb.2016.09.027","volume":"1035","author":"L Glicksberg","year":"2016","unstructured":"Glicksberg L, Bryand K, Kerrigan S (2016) Identification and quantification of synthetic cathinones in blood and urine using liquid chromatography-quadrupole\/time of flight (LC-Q\/TOF) mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 1035:91\u2013103. \nhttps:\/\/doi.org\/10.1016\/j.jchromb.2016.09.027","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"260_CR45","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/clinchem\/39.4.670","volume":"39","author":"BA Goldberger","year":"1993","unstructured":"Goldberger BA, Darwin WD, Grant TM, Allen AC, Caplan YH, Cone EJ (1993) Measurement of heroin and its metabolites by isotope-dilution electron-impact mass spectrometry. Clin Chem 39:670\u2013675","journal-title":"Clin Chem"},{"key":"260_CR46","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.disamonth.2008.10.002","volume":"55","author":"RA Goldstein","year":"2009","unstructured":"Goldstein RA, DesLauriers C, Burda AM (2009) Cocaine: history, social implications, and toxicity--a review. Dis Mon 55:6\u201338. \nhttps:\/\/doi.org\/10.1016\/j.disamonth.2008.10.002","journal-title":"Dis Mon"},{"key":"260_CR47","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.mcna.2018.02.010","volume":"102","author":"R Graddy","year":"2018","unstructured":"Graddy R, Buresh ME, Rastegar DA (2018) New and emerging illicit psychoactive substances. Med Clin North Am 102:697\u2013714. \nhttps:\/\/doi.org\/10.1016\/j.mcna.2018.02.010","journal-title":"Med Clin North Am"},{"key":"260_CR48","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1002\/bmc.1059","volume":"22","author":"S Grinberga","year":"2008","unstructured":"Grinberga S, Zvejniece L, Liepinsh E, Dambrova M, Pugovics O (2008) Quantitative analysis of phenibut in rat brain tissue extracts by liquid chromatography-tandem mass spectrometry. Biomed Chromatogr 22:1321\u20131324. \nhttps:\/\/doi.org\/10.1002\/bmc.1059","journal-title":"Biomed Chromatogr"},{"key":"260_CR49","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","volume":"42","author":"F Grotenhermen","year":"2003","unstructured":"Grotenhermen F (2003) Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet 42:327\u2013360. \nhttps:\/\/doi.org\/10.2165\/00003088-200342040-00003","journal-title":"Clin Pharmacokinet"},{"key":"260_CR50","doi-asserted-by":"publisher","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","volume":"66","author":"GP Guy Jr","year":"2017","unstructured":"Guy GP Jr, Zhang K, Bohm MK, Losby J, Lewis B, Young R, Murphy LB, Dowell D (2017) Vital signs: changes in opioid prescribing in the United States, 2006-2015. MMWR Morb Mortal Wkly Rep 66:697\u2013704. \nhttps:\/\/doi.org\/10.15585\/mmwr.mm6626a4","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"260_CR51","doi-asserted-by":"publisher","first-page":"1382.e1","DOI":"10.1016\/j.amjmed.2018.04.025","volume":"131","author":"S Hassamal","year":"2018","unstructured":"Hassamal S, Miotto K, Dale W, Danovitch I (2018) Tramadol: understanding the risk of serotonin syndrome and seizures. Am J Med 131:1382.e1\u20131382.e6. \nhttps:\/\/doi.org\/10.1016\/j.amjmed.2018.04.025","journal-title":"Am J Med"},{"key":"260_CR52","first-page":"1","volume":"294","author":"H Hedegaard","year":"2017","unstructured":"Hedegaard H, Warner M, Minino AM (2017) Drug overdose deaths in the United States, 1999-2016. NCHS Data Brief 294:1\u20138","journal-title":"NCHS Data Brief"},{"key":"260_CR53","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3109\/15563650.2015.1033630","volume":"53","author":"A Helander","year":"2015","unstructured":"Helander A, Beck O, Backberg M (2015) Intoxications by the dissociative new psychoactive substances diphenidine and methoxphenidine. Clin Toxicol (Phila) 53:446\u2013453. \nhttps:\/\/doi.org\/10.3109\/15563650.2015.1033630","journal-title":"Clin Toxicol (Phila)"},{"key":"260_CR54","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1373\/clinchem.2017.275867","volume":"64","author":"SL Hill","year":"2018","unstructured":"Hill SL, Dunn M, Cano C, Harnor SJ, Hardcastle IR, Grundlingh J, Dargan PI, Wood DM, Tucker S, Bartram T, Thomas SHL (2018) Human toxicity caused by indole and indazole carboxylate synthetic cannabinoid receptor agonists: from horizon scanning to notification. Clin Chem 64:346\u2013354. \nhttps:\/\/doi.org\/10.1373\/clinchem.2017.275867","journal-title":"Clin Chem"},{"key":"260_CR55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/bcpt.12655","volume":"120","author":"JT Horsfall","year":"2017","unstructured":"Horsfall JT, Sprague JE (2017) The pharmacology and toxicology of the \u2018Holy Trinity\u2019. Basic Clin Pharmacol Toxicol 120:115\u2013119. \nhttps:\/\/doi.org\/10.1111\/bcpt.12655","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"260_CR56","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jpba.2013.08.026","volume":"88","author":"XL Hou","year":"2014","unstructured":"Hou XL, Wu YL, Chen RX, Zhu Y, Lv Y, Xu XQ (2014) Evaluation of two modified quick, easy, cheap, effective, rugged and safe (QuEChERS) sample preparation methods for the analysis of baclofen and gabapentin in feeds by liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal 88:53\u201359. \nhttps:\/\/doi.org\/10.1016\/j.jpba.2013.08.026","journal-title":"J Pharm Biomed Anal"},{"key":"260_CR57","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0028-3908(90)90056-W","volume":"29","author":"AC Howlett","year":"1990","unstructured":"Howlett AC, Champion TM, Wilken GH, Mechoulam R (1990) Stereochemical effects of 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor. Neuropharmacology 29:161\u2013165","journal-title":"Neuropharmacology"},{"key":"260_CR58","doi-asserted-by":"publisher","first-page":"eaau1184","DOI":"10.1126\/science.aau1184","volume":"361","author":"H Jalal","year":"2018","unstructured":"Jalal H, Buchanich JM, Roberts MS, Balmert LC, Zhang K, Burke DS (2018) Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016. Science 361:eaau1184. \nhttps:\/\/doi.org\/10.1126\/science.aau1184","journal-title":"Science"},{"key":"260_CR59","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0378-8741(88)90121-3","volume":"23","author":"KL Jansen","year":"1988","unstructured":"Jansen KL, Prast CJ (1988) Ethnopharmacology of kratom and the Mitragyna alkaloids. J Ethnopharmacol 23:115\u2013119","journal-title":"J Ethnopharmacol"},{"key":"260_CR60","doi-asserted-by":"publisher","first-page":"4943","DOI":"10.2174\/1381612821666150914121624","volume":"21","author":"MJ Jembrek","year":"2015","unstructured":"Jembrek MJ, Vlainic J (2015) GABA receptors: pharmacological potential and pitfalls. Curr Pharm Des 21:4943\u20134959","journal-title":"Curr Pharm Des"},{"key":"260_CR61","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40122-018-0097-6","volume":"7","author":"MR Jones","year":"2018","unstructured":"Jones MR, Viswanath O, Peck J, Kaye AD, Gill JS, Simopoulos TT (2018) A brief history of the opioid epidemic and strategies for pain medicine. Pain Ther 7:13\u201321. \nhttps:\/\/doi.org\/10.1007\/s40122-018-0097-6","journal-title":"Pain Ther"},{"key":"260_CR62","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1600-0773.1992.tb00434.x","volume":"70","author":"P Kalix","year":"1992","unstructured":"Kalix P (1992) Cathinone, a natural amphetamine. Pharmacol Toxicol 70:77\u201386","journal-title":"Pharmacol Toxicol"},{"key":"260_CR63","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/1570159X13666141210225009","volume":"13","author":"SB Karch","year":"2015","unstructured":"Karch SB (2015) Cathinone neurotoxicity (\u201cThe 3Ms\u201d). Curr Neuropharmacol 13:21\u201325. \nhttps:\/\/doi.org\/10.2174\/1570159X13666141210225009","journal-title":"Curr Neuropharmacol"},{"key":"260_CR64","doi-asserted-by":"publisher","first-page":"290","DOI":"10.5811\/westjem.2016.2.29519","volume":"17","author":"KD Katz","year":"2016","unstructured":"Katz KD, Leonetti AL, Bailey BC, Surmaitis RM, Eustice ER, Kacinko S, Wheatley SM (2016) Case series of synthetic cannabinoid intoxication from one toxicology center. West J Emerg Med 17:290\u2013294. \nhttps:\/\/doi.org\/10.5811\/westjem.2016.2.29519","journal-title":"West J Emerg Med"},{"key":"260_CR65","doi-asserted-by":"publisher","first-page":"4.43.1","DOI":"10.1002\/cptx.33","volume":"74","author":"H Ketha","year":"2017","unstructured":"Ketha H, Webb M, Clayton L, Li S (2017) Gas chromatography mass spectrometry (GC-MS) for identification of designer stimulants including 2C amines, NBOMe compounds, and cathinones in urine. Curr Protoc Toxicol 74:4.43.1\u20134.43.10. \nhttps:\/\/doi.org\/10.1002\/cptx.33","journal-title":"Curr Protoc Toxicol"},{"issue":"444","key":"260_CR66","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.ajem.2012.05.028","volume":"31","author":"AM King","year":"2013","unstructured":"King AM, Pugh JL, Menke NB, Krasowski MD, Lynch MJ, Pizon AF (2013) Nonfatal tramadol overdose may cause false-positive phencyclidine on Emit-II assay. Am J Emerg Med 31(444):e5\u2013e9. \nhttps:\/\/doi.org\/10.1016\/j.ajem.2012.05.028","journal-title":"Am J Emerg Med"},{"key":"260_CR67","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/jat\/bkv137","volume":"40","author":"JL Knittel","year":"2016","unstructured":"Knittel JL, Holler JM, Chmiel JD, Vorce SP, Magluilo J Jr, Levine B, Ramos G, Bosy TZ (2016) Analysis of parent synthetic cannabinoids in blood and urinary metabolites by liquid chromatography tandem mass spectrometry. J Anal Toxicol 40:173\u2013186. \nhttps:\/\/doi.org\/10.1093\/jat\/bkv137","journal-title":"J Anal Toxicol"},{"key":"260_CR68","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1758-2946-6-22","volume":"6","author":"MD Krasowski","year":"2014","unstructured":"Krasowski MD, Ekins S (2014) Using cheminformatics to predict cross reactivity of \u201cdesigner drugs\u201d to their currently available immunoassays. J Cheminform 6:22. \nhttps:\/\/doi.org\/10.1186\/1758-2946-6-22","journal-title":"J Cheminform"},{"key":"260_CR69","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-227X-9-5","volume":"9","author":"MD Krasowski","year":"2009","unstructured":"Krasowski MD, Pizon AF, Siam MG, Giannoutsos S, Iyer M, Ekins S (2009) Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse\/toxicology screening in emergency medicine. BMC Emerg Med 9:5. \nhttps:\/\/doi.org\/10.1186\/1471-227X-9-5","journal-title":"BMC Emerg Med"},{"key":"260_CR70","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1172\/JCI60390","volume":"122","author":"MJ Kreek","year":"2012","unstructured":"Kreek MJ, Levran O, Reed B, Schlussman SD, Zhou Y, Butelman ER (2012) Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics. J Clin Invest 122:3387\u20133393. \nhttps:\/\/doi.org\/10.1172\/JCI60390","journal-title":"J Clin Invest"},{"key":"260_CR71","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.neuropharm.2017.08.026","volume":"134","author":"AC Kruegel","year":"2018","unstructured":"Kruegel AC, Grundmann O (2018) The medicinal chemistry and neuropharmacology of kratom: a preliminary discussion of a promising medicinal plant and analysis of its potential for abuse. Neuropharmacology 134:108\u2013120. \nhttps:\/\/doi.org\/10.1016\/j.neuropharm.2017.08.026","journal-title":"Neuropharmacology"},{"key":"260_CR72","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s13181-016-0587-z","volume":"13","author":"K Kulig","year":"2017","unstructured":"Kulig K (2017) Interpretation of workplace tests for cannabinoids. J Med Toxicol 13:106\u2013110. \nhttps:\/\/doi.org\/10.1007\/s13181-016-0587-z","journal-title":"J Med Toxicol"},{"key":"260_CR73","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fpsyt.2013.00052","volume":"4","author":"SE Lakhan","year":"2013","unstructured":"Lakhan SE, Caro M, Hadzimichalis N (2013) NMDA receptor activity in neuropsychiatric disorders. Front Psychiatry 4:52. \nhttps:\/\/doi.org\/10.3389\/fpsyt.2013.00052","journal-title":"Front Psychiatry"},{"key":"260_CR74","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1527-3458.2001.tb00211.x","volume":"7","author":"I Lapin","year":"2001","unstructured":"Lapin I (2001) Phenibut (beta-phenyl-GABA): a tranquilizer and nootropic drug. CNS Drug Rev 7:471\u2013481","journal-title":"CNS Drug Rev"},{"key":"260_CR75","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1136\/jnnp-2017-316071","volume":"88","author":"JM Lappin","year":"2017","unstructured":"Lappin JM, Darke S, Farrell M (2017) Stroke and methamphetamine use in young adults: a review. J Neurol Neurosurg Psychiatry 88:1079\u20131091. \nhttps:\/\/doi.org\/10.1136\/jnnp-2017-316071","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"260_CR76","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s13181-014-0445-9","volume":"11","author":"LK Laskowski","year":"2015","unstructured":"Laskowski LK, Elbakoush F, Calvo J, Exantus-Bernard G, Fong J, Poklis JL, Poklis A, Nelson LS (2015) Evolution of the NBOMes: 25C- and 25B- sold as 25I-NBOMe. J Med Toxicol 11:237\u2013241. \nhttps:\/\/doi.org\/10.1007\/s13181-014-0445-9","journal-title":"J Med Toxicol"},{"key":"260_CR77","first-page":"618","volume":"64","author":"R Law","year":"2015","unstructured":"Law R, Schier J, Martin C, Chang A, Wolkin A, Centers for Disease C (2015) Notes from the field: increase in reported adverse health effects related to synthetic cannabinoid use \u2013 United States, January\u2013May 2015. MMWR Morb Mortal Wkly Rep 64:618\u2013619","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"260_CR78","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.forsciint.2017.06.002","volume":"277","author":"HZS Lee","year":"2017","unstructured":"Lee HZS, Ong MC, Lim JLW, Yap TWA (2017) Challenges in GC-MS analysis: case studies on phenibut and ethylphenidate. Forensic Sci Int 277:166\u2013178. \nhttps:\/\/doi.org\/10.1016\/j.forsciint.2017.06.002","journal-title":"Forensic Sci Int"},{"key":"260_CR79","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/cpt1975186720","volume":"18","author":"L Lemberger","year":"1975","unstructured":"Lemberger L, Rowe H (1975) Clinical pharmacology of nabilone, a cannabinol derivative. Clin Pharmacol Ther 18:720\u2013726","journal-title":"Clin Pharmacol Ther"},{"key":"260_CR80","first-page":"149","volume":"232","author":"GS Ling","year":"1985","unstructured":"Ling GS, Spiegel K, Lockhart SH, Pasternak GW (1985) Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms. J Pharmacol Exp Ther 232:149\u2013155","journal-title":"J Pharmacol Exp Ther"},{"key":"260_CR81","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/S1734-1140(11)70694-6","volume":"63","author":"J Listos","year":"2011","unstructured":"Listos J, Merska A, Fidecka S (2011) Pharmacological activity of salvinorin A, the major component of Salvia divinorum. Pharmacol Rep 63:1305\u20131309","journal-title":"Pharmacol Rep"},{"key":"260_CR82","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3109\/15563650.2016.1138226","volume":"54","author":"RP Litjens","year":"2016","unstructured":"Litjens RP, Brunt TM (2016) How toxic is ibogaine? Clin Toxicol (Phila) 54:297\u2013302. \nhttps:\/\/doi.org\/10.3109\/15563650.2016.1138226","journal-title":"Clin Toxicol (Phila)"},{"key":"260_CR83","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/ajcp\/aqx138","volume":"149","author":"L Liu","year":"2018","unstructured":"Liu L, Wheeler SE, Venkataramanan R, Rymer JA, Pizon AF, Lynch MJ, Tamama K (2018) Newly emerging drugs of abuse and their detection methods: an ACLPS critical review. Am J Clin Pathol 149:105\u2013116. \nhttps:\/\/doi.org\/10.1093\/ajcp\/aqx138","journal-title":"Am J Clin Pathol"},{"key":"260_CR84","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.1111\/bph.13222","volume":"172","author":"D Lodge","year":"2015","unstructured":"Lodge D, Mercier MS (2015) Ketamine and phencyclidine: the good, the bad and the unexpected. Br J Pharmacol 172:4254\u20134276. \nhttps:\/\/doi.org\/10.1111\/bph.13222","journal-title":"Br J Pharmacol"},{"key":"260_CR85","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.drugalcdep.2009.05.027","volume":"105","author":"RH Lowe","year":"2009","unstructured":"Lowe RH, Abraham TT, Darwin WD, Herning R, Cadet JL, Huestis MA (2009) Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure. Drug Alcohol Depend 105:24\u201332. \nhttps:\/\/doi.org\/10.1016\/j.drugalcdep.2009.05.027","journal-title":"Drug Alcohol Depend"},{"key":"260_CR86","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/dta.2244","volume":"10","author":"A Maas","year":"2018","unstructured":"Maas A, Madea B, Hess C (2018) Confirmation of recent heroin abuse: accepting the challenge. Drug Test Anal 10:54\u201371. \nhttps:\/\/doi.org\/10.1002\/dta.2244","journal-title":"Drug Test Anal"},{"key":"260_CR87","doi-asserted-by":"publisher","first-page":"20630","DOI":"10.2807\/1560-7917.ES2013.18.45.20630","volume":"18","author":"E MacDonald","year":"2013","unstructured":"MacDonald E, Arnesen TM, Brantsaeter AB, Gerlyng P, Grepp M, Hansen BA, Jonsrud K, Lundgren B, Mellegard H, Moller-Stray J, Ronning K, Vestrheim DF, Vold L (2013) Outbreak of wound botulism in people who inject drugs, Norway, October to November 2013. Euro Surveill 18:20630","journal-title":"Euro Surveill"},{"key":"260_CR88","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/dta.1371","volume":"5","author":"AM Macher","year":"2013","unstructured":"Macher AM, Penders TM (2013) False-positive phencyclidine immunoassay results caused by 3,4-methylenedioxypyrovalerone (MDPV). Drug Test Anal 5:130\u2013132. \nhttps:\/\/doi.org\/10.1002\/dta.1371","journal-title":"Drug Test Anal"},{"key":"260_CR89","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.2105\/AJPH.2015.302843","volume":"105","author":"SS Martins","year":"2015","unstructured":"Martins SS, Sampson L, Cerda M, Galea S (2015) Worldwide prevalence and trends in unintentional drug overdose: a systematic review of the literature. Am J Public Health 105:e29\u2013e49. \nhttps:\/\/doi.org\/10.2105\/AJPH.2015.302843","journal-title":"Am J Public Health"},{"key":"260_CR90","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.pharmthera.2014.05.001","volume":"144","author":"RR Matsumoto","year":"2014","unstructured":"Matsumoto RR, Seminerio MJ, Turner RC, Robson MJ, Nguyen L, Miller DB, O\u2019Callaghan JP (2014) Methamphetamine-induced toxicity: an updated review on issues related to hyperthermia. Pharmacol Ther 144:28\u201340. \nhttps:\/\/doi.org\/10.1016\/j.pharmthera.2014.05.001","journal-title":"Pharmacol Ther"},{"key":"260_CR91","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/add.13326","volume":"111","author":"R McDonald","year":"2016","unstructured":"McDonald R, Strang J (2016) Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. Addiction 111:1177\u20131187. \nhttps:\/\/doi.org\/10.1111\/add.13326","journal-title":"Addiction"},{"key":"260_CR92","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1126\/science.168.3936.1159","volume":"168","author":"R Mechoulam","year":"1970","unstructured":"Mechoulam R (1970) Marihuana chemistry. Science 168:1159\u20131166","journal-title":"Science"},{"key":"260_CR93","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.2174\/1381612003399509","volume":"6","author":"R Mechoulam","year":"2000","unstructured":"Mechoulam R (2000) Looking back at Cannabis research. Curr Pharm Des 6:1313\u20131322","journal-title":"Curr Pharm Des"},{"key":"260_CR94","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.cbi.2013.10.011","volume":"206","author":"B Megarbane","year":"2013","unstructured":"Megarbane B, Chevillard L (2013) The large spectrum of pulmonary complications following illicit drug use: features and mechanisms. Chem Biol Interact 206:444\u2013451. \nhttps:\/\/doi.org\/10.1016\/j.cbi.2013.10.011","journal-title":"Chem Biol Interact"},{"key":"260_CR95","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3389\/fnins.2016.00153","volume":"10","author":"C Miliano","year":"2016","unstructured":"Miliano C, Serpelloni G, Rimondo C, Mereu M, Marti M, De Luca MA (2016) Neuropharmacology of new psychoactive substances (NPS): focus on the rewarding and reinforcing properties of cannabimimetics and amphetamine-like stimulants. Front Neurosci 10:153. \nhttps:\/\/doi.org\/10.3389\/fnins.2016.00153","journal-title":"Front Neurosci"},{"key":"260_CR96","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0168-0102(95)00933-K","volume":"23","author":"M Minami","year":"1995","unstructured":"Minami M, Satoh M (1995) Molecular biology of the opioid receptors: structures, functions and distributions. Neurosci Res 23:121\u2013145","journal-title":"Neurosci Res"},{"key":"260_CR97","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s40263-018-0519-3","volume":"32","author":"P Molero","year":"2018","unstructured":"Molero P, Ramos-Quiroga JA, Martin-Santos R, Calvo-Sanchez E, Gutierrez-Rojas L, Meana JJ (2018) Antidepressant efficacy and tolerability of ketamine and esketamine: a critical review. CNS Drugs 32:411\u2013420. \nhttps:\/\/doi.org\/10.1007\/s40263-018-0519-3","journal-title":"CNS Drugs"},{"key":"260_CR98","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/dta.1620","volume":"6","author":"H Morris","year":"2014","unstructured":"Morris H, Wallach J (2014) From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs. Drug Test Anal 6:614\u2013632. \nhttps:\/\/doi.org\/10.1002\/dta.1620","journal-title":"Drug Test Anal"},{"key":"260_CR99","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1080\/15563650.2016.1245421","volume":"54","author":"JB Mowry","year":"2016","unstructured":"Mowry JB, Spyker DA, Brooks DE, Zimmerman A, Schauben JL (2016) 2015 annual report of the American Association of Poison Control Centers\u2019 national poison data system (NPDS): 33rd annual report. Clin Toxicol (Phila) 54:924\u20131109. \nhttps:\/\/doi.org\/10.1080\/15563650.2016.1245421","journal-title":"Clin Toxicol (Phila)"},{"key":"260_CR100","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s11419-015-0270-0","volume":"33","author":"A Namera","year":"2015","unstructured":"Namera A, Kawamura M, Nakamoto A, Saito T, Nagao M (2015) Comprehensive review of the detection methods for synthetic cannabinoids and cathinones. Forensic Toxicol 33:175\u2013194. \nhttps:\/\/doi.org\/10.1007\/s11419-015-0270-0","journal-title":"Forensic Toxicol"},{"key":"260_CR101","volume-title":"The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research","author":"National Academies of Sciences E and Medicine","year":"2017","unstructured":"National Academies of Sciences E and Medicine (2017) The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. The National Academies Press, Washington"},{"key":"260_CR102","unstructured":"National Institute on Drug Abuse (NIDA) (2018) Overdose death rates. \nhttps:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/overdose-death-rates\n\n. Accessed 15 Nov 2018"},{"key":"260_CR103","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.15585\/mmwr.mm6643e1","volume":"66","author":"JK O\u2019Donnell","year":"2017","unstructured":"O\u2019Donnell JK, Halpin J, Mattson CL, Goldberger BA, Gladden RM (2017) Deaths involving fentanyl, fentanyl analogs, and U-47700 \u2013 10 states, July-December 2016. MMWR Morb Mortal Wkly Rep 66:1197\u20131202. \nhttps:\/\/doi.org\/10.15585\/mmwr.mm6643e1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"260_CR104","doi-asserted-by":"publisher","first-page":"236","DOI":"10.26719\/2017.23.3.236","volume":"23","author":"M Odenwald","year":"2017","unstructured":"Odenwald M, al\u2019Absi M (2017) Khat use and related addiction, mental health and physical disorders: the need to address a growing risk. East Mediterr Health J 23:236\u2013244","journal-title":"East Mediterr Health J"},{"key":"260_CR105","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.08.028","volume":"156","author":"JJ Palamar","year":"2015","unstructured":"Palamar JJ, Martins SS, Su MK, Ompad DC (2015) Self-reported use of novel psychoactive substances in a US nationally representative survey: prevalence, correlates, and a call for new survey methods to prevent underreporting. Drug Alcohol Depend 156:112\u2013119. \nhttps:\/\/doi.org\/10.1016\/j.drugalcdep.2015.08.028","journal-title":"Drug Alcohol Depend"},{"key":"260_CR106","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3201\/eid1901.120044","volume":"19","author":"NE Palmateer","year":"2013","unstructured":"Palmateer NE, Hope VD, Roy K, Marongiu A, White JM, Grant KA, Ramsay CN, Goldberg DJ, Ncube F (2013) Infections with spore-forming bacteria in persons who inject drugs, 2000-2009. Emerg Infect Dis 19:29\u201334. \nhttps:\/\/doi.org\/10.3201\/eid1901.120044","journal-title":"Emerg Infect Dis"},{"key":"260_CR107","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/dar.12372","volume":"35","author":"ME Patrick","year":"2016","unstructured":"Patrick ME, O\u2019Malley PM, Kloska DD, Schulenberg JE, Johnston LD, Miech RA, Bachman JG (2016) Novel psychoactive substance use by US adolescents: characteristics associated with use of synthetic cannabinoids and synthetic cathinones. Drug Alcohol Rev 35:586\u2013590. \nhttps:\/\/doi.org\/10.1111\/dar.12372","journal-title":"Drug Alcohol Rev"},{"key":"260_CR108","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s40262-016-0383-6","volume":"55","author":"MA Peltoniemi","year":"2016","unstructured":"Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI (2016) Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy. Clin Pharmacokinet 55:1059\u20131077. \nhttps:\/\/doi.org\/10.1007\/s40262-016-0383-6","journal-title":"Clin Pharmacokinet"},{"key":"260_CR109","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/bcpt.12434","volume":"118","author":"EI Penninga","year":"2016","unstructured":"Penninga EI, Graudal N, Ladekarl MB, Jurgens G (2016) Adverse events associated with flumazenil treatment for the management of suspected benzodiazepine intoxication \u2013 a systematic review with meta-analyses of randomised trials. Basic Clin Pharmacol Toxicol 118:37\u201344. \nhttps:\/\/doi.org\/10.1111\/bcpt.12434","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"260_CR110","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/FTD.0b013e3181f33411","volume":"32","author":"FT Peters","year":"2010","unstructured":"Peters FT, Martinez-Ramirez JA (2010) Analytical toxicology of emerging drugs of abuse. Ther Drug Monit 32:532\u2013539. \nhttps:\/\/doi.org\/10.1097\/FTD.0b013e3181f33411","journal-title":"Ther Drug Monit"},{"key":"260_CR111","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3109\/15563650.2013.768344","volume":"51","author":"M Petrie","year":"2013","unstructured":"Petrie M, Lynch KL, Ekins S, Chang JS, Goetz RJ, Wu AH, Krasowski MD (2013) Cross-reactivity studies and predictive modeling of \u201cBath salts\u201d and other amphetamine-type stimulants with amphetamine screening immunoassays. Clin Toxicol (Phila) 51:83\u201391. \nhttps:\/\/doi.org\/10.3109\/15563650.2013.768344","journal-title":"Clin Toxicol (Phila)"},{"key":"260_CR112","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/dta.2003","volume":"9","author":"M Pettersson Bergstrand","year":"2017","unstructured":"Pettersson Bergstrand M, Helander A, Hansson T, Beck O (2017) Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays. Drug Test Anal 9:640\u2013645. \nhttps:\/\/doi.org\/10.1002\/dta.2003","journal-title":"Drug Test Anal"},{"key":"260_CR113","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1007\/s11606-012-2089-2","volume":"27","author":"KA Phillips","year":"2012","unstructured":"Phillips KA, Hirsch GA, Epstein DH, Preston KL (2012) Cardiac complications of unwitting co-injection of quinine\/quinidine with heroin in an intravenous drug user. J Gen Intern Med 27:1722\u20131725. \nhttps:\/\/doi.org\/10.1007\/s11606-012-2089-2","journal-title":"J Gen Intern Med"},{"key":"260_CR114","doi-asserted-by":"publisher","first-page":"e768","DOI":"10.1097\/CCM.0000000000003204","volume":"46","author":"AF Pizon","year":"2018","unstructured":"Pizon AF, Lynch MJ, Benedict NJ, Yanta JH, Frisch A, Menke NB, Swartzentruber GS, King AM, Abesamis MG, Kane-Gill SL (2018) Adjunct ketamine use in the management of severe ethanol withdrawal. Crit Care Med 46:e768\u2013e771. \nhttps:\/\/doi.org\/10.1097\/CCM.0000000000003204","journal-title":"Crit Care Med"},{"key":"260_CR115","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1021\/acschemneuro.8b00459","volume":"9","author":"CC Presley","year":"2018","unstructured":"Presley CC, Lindsley CW (2018) DARK classics in chemical neuroscience: opium, a historical perspective. ACS Chem Neurosci 9:2503\u20132518. \nhttps:\/\/doi.org\/10.1021\/acschemneuro.8b00459","journal-title":"ACS Chem Neurosci"},{"key":"260_CR116","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s13181-011-0193-z","volume":"8","author":"JM Prosser","year":"2012","unstructured":"Prosser JM, Nelson LS (2012) The toxicology of bath salts: a review of synthetic cathinones. J Med Toxicol 8:33\u201342. \nhttps:\/\/doi.org\/10.1007\/s13181-011-0193-z","journal-title":"J Med Toxicol"},{"key":"260_CR117","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/jat\/bku133","volume":"39","author":"LE Regester","year":"2015","unstructured":"Regester LE, Chmiel JD, Holler JM, Vorce SP, Levine B, Bosy TZ (2015) Determination of designer drug cross-reactivity on five commercial immunoassay screening kits. J Anal Toxicol 39:144\u2013151. \nhttps:\/\/doi.org\/10.1093\/jat\/bku133","journal-title":"J Anal Toxicol"},{"key":"260_CR118","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1177\/1074248416681644","volume":"22","author":"JR Richards","year":"2017","unstructured":"Richards JR, Hollander JE, Ramoska EA, Fareed FN, Sand IC, Izquierdo Gomez MM, Lange RA (2017) Beta-blockers, cocaine, and the unopposed alpha-stimulation phenomenon. J Cardiovasc Pharmacol Ther 22:239\u2013249. \nhttps:\/\/doi.org\/10.1177\/1074248416681644","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"260_CR119","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.bmcl.2018.03.029","volume":"28","author":"JJ Roach","year":"2018","unstructured":"Roach JJ, Shenvi RA (2018) A review of salvinorin analogs and their kappa-opioid receptor activity. Bioorg Med Chem Lett 28:1436\u20131445. \nhttps:\/\/doi.org\/10.1016\/j.bmcl.2018.03.029","journal-title":"Bioorg Med Chem Lett"},{"key":"260_CR120","doi-asserted-by":"publisher","first-page":"307106","DOI":"10.1155\/2014\/307106","volume":"2014","author":"B Rolland","year":"2014","unstructured":"Rolland B, Jardri R, Amad A, Thomas P, Cottencin O, Bordet R (2014) Pharmacology of hallucinations: several mechanisms for one single symptom? Biomed Res Int 2014:307106. \nhttps:\/\/doi.org\/10.1155\/2014\/307106","journal-title":"Biomed Res Int"},{"key":"260_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.forsciint.2014.03.015","volume":"240","author":"K Ruiz-Colon","year":"2014","unstructured":"Ruiz-Colon K, Chavez-Arias C, Diaz-Alcala JE, Martinez MA (2014) Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: a comprehensive review of the literature. Forensic Sci Int 240:1\u20138. \nhttps:\/\/doi.org\/10.1016\/j.forsciint.2014.03.015","journal-title":"Forensic Sci Int"},{"key":"260_CR122","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1177\/1087054715605915","volume":"20","author":"DJ Safer","year":"2016","unstructured":"Safer DJ (2016) Recent trends in stimulant usage. J Atten Disord 20:471\u2013477. \nhttps:\/\/doi.org\/10.1177\/1087054715605915","journal-title":"J Atten Disord"},{"issue":"Suppl 1","key":"260_CR123","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2165\/00023210-200418001-00004","volume":"18","author":"DJ Sanger","year":"2004","unstructured":"Sanger DJ (2004) The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents. CNS Drugs 18(Suppl 1):9\u201315; discussion 41, 43\u201345. \nhttps:\/\/doi.org\/10.2165\/00023210-200418001-00004","journal-title":"CNS Drugs"},{"key":"260_CR124","unstructured":"Satzinger G, Hartenstein J, Herrmann M, Heldt W (1975) Cyclic amino acids. US4024175A"},{"key":"260_CR125","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.chroma.2013.12.067","volume":"1327","author":"KB Scheidweiler","year":"2014","unstructured":"Scheidweiler KB, Huestis MA (2014) Simultaneous quantification of 20 synthetic cannabinoids and 21 metabolites, and semi-quantification of 12 alkyl hydroxy metabolites in human urine by liquid chromatography-tandem mass spectrometry. J Chromatogr A 1327:105\u2013117. \nhttps:\/\/doi.org\/10.1016\/j.chroma.2013.12.067","journal-title":"J Chromatogr A"},{"key":"260_CR126","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3109\/15563650.2012.702218","volume":"50","author":"LJ Schep","year":"2012","unstructured":"Schep LJ, Knudsen K, Slaughter RJ, Vale JA, Megarbane B (2012) The clinical toxicology of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol. Clin Toxicol (Phila) 50:458\u2013470. \nhttps:\/\/doi.org\/10.3109\/15563650.2012.702218","journal-title":"Clin Toxicol (Phila)"},{"key":"260_CR127","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/clinchem\/48.4.676","volume":"48","author":"SF Sena","year":"2002","unstructured":"Sena SF, Kazimi S, Wu AH (2002) False-positive phencyclidine immunoassay results caused by venlafaxine and O-desmethylvenlafaxine. Clin Chem 48:676\u2013677","journal-title":"Clin Chem"},{"key":"260_CR128","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ejphar.2015.05.012","volume":"763","author":"Y Shang","year":"2015","unstructured":"Shang Y, Filizola M (2015) Opioid receptors: structural and mechanistic insights into pharmacology and signaling. Eur J Pharmacol 763:206\u2013213. \nhttps:\/\/doi.org\/10.1016\/j.ejphar.2015.05.012","journal-title":"Eur J Pharmacol"},{"key":"260_CR129","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1080\/15563650.2017.1348043","volume":"55","author":"J Shulman","year":"2017","unstructured":"Shulman J, Pizon A, Lynch M (2017) Trends in gabapentin abuse reported to poison centers, 2012-2015 (abstract). Clin Toxicol (Phila) 55:689\u2013868. \nhttps:\/\/doi.org\/10.1080\/15563650.2017.1348043","journal-title":"Clin Toxicol (Phila)"},{"key":"260_CR130","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/bs.apha.2014.10.002","volume":"72","author":"W Sieghart","year":"2015","unstructured":"Sieghart W (2015) Allosteric modulation of GABAA receptors via multiple drug-binding sites. Adv Pharmacol 72:53\u201396. \nhttps:\/\/doi.org\/10.1016\/bs.apha.2014.10.002","journal-title":"Adv Pharmacol"},{"issue":"Pt 5","key":"260_CR131","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1177\/000456329703400502","volume":"34","author":"D Simpson","year":"1997","unstructured":"Simpson D, Braithwaite RA, Jarvie DR, Stewart MJ, Walker S, Watson IW, Widdop B (1997) Screening for drugs of abuse (II): cannabinoids, lysergic acid diethylamide, buprenorphine, methadone, barbiturates, benzodiazepines and other drugs. Ann Clin Biochem 34(Pt 5):460\u2013510. \nhttps:\/\/doi.org\/10.1177\/000456329703400502","journal-title":"Ann Clin Biochem"},{"key":"260_CR132","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/978-3-540-74806-9_15","volume":"182","author":"B Sinner","year":"2008","unstructured":"Sinner B, Graf BM (2008) Ketamine. Handb Exp Pharmacol 182:313\u2013333. \nhttps:\/\/doi.org\/10.1007\/978-3-540-74806-9_15","journal-title":"Handb Exp Pharmacol"},{"issue":"5","key":"260_CR133","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1177\/0004563219858125","volume":"56","author":"John M Skaugen","year":"2019","unstructured":"Skaugen JM, Scoccimarro A, Pizon AF, Rymer JA, Giannoutsos S, Ekins S, Krasowski MD, Tamama K (2019) Novel ketamine analogs cause a false positive phencyclidine immunoassay. Ann Clin Biochem 56:598\u2013607. \nhttps:\/\/doi.org\/10.1177\/0004563219858125","journal-title":"Annals of Clinical Biochemistry: International Journal of Laboratory Medicine"},{"key":"260_CR134","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.1039\/c5an00797f","volume":"140","author":"JP Smith","year":"2015","unstructured":"Smith JP, Sutcliffe OB, Banks CE (2015) An overview of recent developments in the analytical detection of new psychoactive substances (NPSs). Analyst 140:4932\u20134948. \nhttps:\/\/doi.org\/10.1039\/c5an00797f","journal-title":"Analyst"},{"key":"260_CR135","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/add.13324","volume":"111","author":"RV Smith","year":"2016","unstructured":"Smith RV, Havens JR, Walsh SL (2016) Gabapentin misuse, abuse and diversion: a systematic review. Addiction 111:1160\u20131174. \nhttps:\/\/doi.org\/10.1111\/add.13324","journal-title":"Addiction"},{"key":"260_CR136","doi-asserted-by":"publisher","first-page":"524","DOI":"10.2174\/1389201018666170710184531","volume":"18","author":"R Solimini","year":"2017","unstructured":"Solimini R, Rotolo MC, Pellegrini M, Minutillo A, Pacifici R, Busardo FP, Zaami S (2017) Adulteration practices of psychoactive illicit drugs: an updated review. Curr Pharm Biotechnol 18:524\u2013530. \nhttps:\/\/doi.org\/10.2174\/1389201018666170710184531","journal-title":"Curr Pharm Biotechnol"},{"key":"260_CR137","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s13181-016-0595-z","volume":"13","author":"CJ Sorensen","year":"2017","unstructured":"Sorensen CJ, DeSanto K, Borgelt L, Phillips KT, Monte AA (2017) Cannabinoid hyperemesis syndrome: diagnosis, pathophysiology, and treatment-a systematic review. J Med Toxicol 13:71\u201387. \nhttps:\/\/doi.org\/10.1007\/s13181-016-0595-z","journal-title":"J Med Toxicol"},{"key":"260_CR138","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s40263-013-0084-8","volume":"27","author":"HA Spiller","year":"2013","unstructured":"Spiller HA, Hays HL, Aleguas A Jr (2013) Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management. CNS Drugs 27:531\u2013543. \nhttps:\/\/doi.org\/10.1007\/s40263-013-0084-8","journal-title":"CNS Drugs"},{"key":"260_CR139","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.tcm.2014.12.013","volume":"25","author":"RV Stankowski","year":"2015","unstructured":"Stankowski RV, Kloner RA, Rezkalla SH (2015) Cardiovascular consequences of cocaine use. Trends Cardiovasc Med 25:517\u2013526. \nhttps:\/\/doi.org\/10.1016\/j.tcm.2014.12.013","journal-title":"Trends Cardiovasc Med"},{"key":"260_CR140","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/0885-3924(92)90047-L","volume":"7","author":"TH Stanley","year":"1992","unstructured":"Stanley TH (1992) The history and development of the fentanyl series. J Pain Symptom Manag 7:S3\u2013S7","journal-title":"J Pain Symptom Manag"},{"key":"260_CR141","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1213\/ane.0b013e3181605add","volume":"106","author":"TH Stanley","year":"2008","unstructured":"Stanley TH, Egan TD, Van Aken H (2008) A tribute to Dr. Paul A. J. Janssen: entrepreneur extraordinaire, innovative scientist, and significant contributor to anesthesiology. Anesth Analg 106:451\u2013462, table of contents. \nhttps:\/\/doi.org\/10.1213\/ane.0b013e3181605add","journal-title":"Anesth Analg"},{"key":"260_CR142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/jm00187a001","volume":"22","author":"LH Sternbach","year":"1979","unstructured":"Sternbach LH (1979) The benzodiazepine story. J Med Chem 22:1\u20137","journal-title":"J Med Chem"},{"key":"260_CR143","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1373\/clinchem.2009.137596","volume":"56","author":"JA Straseski","year":"2010","unstructured":"Straseski JA, Stolbach A, Clarke W (2010) Opiate-positive immunoassay screen in a pediatric patient. Clin Chem 56:1220\u20131223. \nhttps:\/\/doi.org\/10.1373\/clinchem.2009.137596","journal-title":"Clin Chem"},{"key":"260_CR144","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA) (2018) Key substance use and mental health indicators in the United States: results from the 2017 National Survey on Drug Use and Health. In: US Department of Health and Human Services (ed)"},{"key":"260_CR145","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/oxfordjournals.jbchem.a003200","volume":"132","author":"T Sugiura","year":"2002","unstructured":"Sugiura T, Waku K (2002) Cannabinoid receptors and their endogenous ligands. J Biochem 132:7\u201312","journal-title":"J Biochem"},{"key":"260_CR146","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.psym.2014.11.002","volume":"56","author":"J Suzuki","year":"2015","unstructured":"Suzuki J, Dekker MA, Valenti ES, Arbelo Cruz FA, Correa AM, Poklis JL, Poklis A (2015) Toxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literature. Psychosomatics 56:129\u2013139. \nhttps:\/\/doi.org\/10.1016\/j.psym.2014.11.002","journal-title":"Psychosomatics"},{"key":"260_CR147","unstructured":"Szmuszkovicz J (1976) Analgesic n-(2-aminocycloaliphatic)benzamides. US4098904A"},{"key":"260_CR148","first-page":"1153","volume":"28","author":"T Tahara","year":"1978","unstructured":"Tahara T, Araki K, Shiroki M, Matsuo H, Munakata T (1978) Syntheses and structure-activity relationships of 6-aryl-4H-s-triazolo[3,4-c]thieno[2,3-e] [1,4]diazepines. Arzneimittelforschung 28:1153\u20131158","journal-title":"Arzneimittelforschung"},{"key":"260_CR149","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1021\/jm010576e","volume":"45","author":"H Takayama","year":"2002","unstructured":"Takayama H, Ishikawa H, Kurihara M, Kitajima M, Aimi N, Ponglux D, Koyama F, Matsumoto K, Moriyama T, Yamamoto LT, Watanabe K, Murayama T, Horie S (2002) Studies on the synthesis and opioid agonistic activities of mitragynine-related indole alkaloids: discovery of opioid agonists structurally different from other opioid ligands. J Med Chem 45:1949\u20131956","journal-title":"J Med Chem"},{"key":"260_CR150","volume-title":"Drug characterization and impurity profiling \u2013 background and concepts","author":"United Nations Office for Drug Control and Crime Prevention (UNODCCP)","year":"2001","unstructured":"United Nations Office for Drug Control and Crime Prevention (UNODCCP) (2001) Drug characterization and impurity profiling \u2013 background and concepts. United Nations Publication, New York"},{"key":"260_CR151","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1093\/clinchem\/44.9.2044","volume":"44","author":"F Van Lente","year":"1998","unstructured":"Van Lente F, Gatautis V (1998) Cost-efficient use of gas chromatography-mass spectrometry: a \u201cpiggyback\u201d method for analysis of gabapentin. Clin Chem 44:2044\u20132045","journal-title":"Clin Chem"},{"key":"260_CR152","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1093\/jat\/bky092","volume":"43","author":"XMR van Wijk","year":"2018","unstructured":"van Wijk XMR, Yun C, Hooshfar S, Arens AM, Lung D, Wu AHB, Lynch KL (2018) A liquid-chromatography high-resolution mass spectrometry method for non-FDA approved benzodiazepines. J Anal Toxicol 43:316\u2013320. \nhttps:\/\/doi.org\/10.1093\/jat\/bky092","journal-title":"J Anal Toxicol"},{"key":"260_CR153","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMra1402309","volume":"370","author":"ND Volkow","year":"2014","unstructured":"Volkow ND, Baler RD, Compton WM, Weiss SR (2014) Adverse health effects of marijuana use. N Engl J Med 370:2219\u20132227. \nhttps:\/\/doi.org\/10.1056\/NEJMra1402309","journal-title":"N Engl J Med"},{"key":"260_CR154","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.2174\/092986709788682074","volume":"16","author":"S Vuckovic","year":"2009","unstructured":"Vuckovic S, Prostran M, Ivanovic M, Dosen-Micovic L, Todorovic Z, Nesic Z, Stojanovic R, Divac N, Mikovic Z (2009) Fentanyl analogs: structure-activity-relationship study. Curr Med Chem 16:2468\u20132474","journal-title":"Curr Med Chem"},{"key":"260_CR155","doi-asserted-by":"publisher","first-page":"f174","DOI":"10.1136\/bmj.f174","volume":"346","author":"AY Walley","year":"2013","unstructured":"Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, Ruiz S, Ozonoff A (2013) Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ 346:f174. \nhttps:\/\/doi.org\/10.1136\/bmj.f174","journal-title":"BMJ"},{"issue":"Suppl 1","key":"260_CR156","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1111\/pme.12911","volume":"16","author":"LR Webster","year":"2015","unstructured":"Webster LR (2015) Opioid-induced constipation. Pain Med 16(Suppl 1):S16\u2013S21. \nhttps:\/\/doi.org\/10.1111\/pme.12911","journal-title":"Pain Med"},{"key":"260_CR157","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fpsyt.2017.00156","volume":"8","author":"AM Weinstein","year":"2017","unstructured":"Weinstein AM, Rosca P, Fattore L, London ED (2017) Synthetic cathinone and cannabinoid designer drugs pose a major risk for public health. Front Psych 8:156. \nhttps:\/\/doi.org\/10.3389\/fpsyt.2017.00156","journal-title":"Front Psych"},{"key":"260_CR158","first-page":"516","volume":"223","author":"A Weissman","year":"1982","unstructured":"Weissman A, Milne GM, Melvin LS Jr (1982) Cannabimimetic activity from CP-47,497, a derivative of 3-phenylcyclohexanol. J Pharmacol Exp Ther 223:516\u2013523","journal-title":"J Pharmacol Exp Ther"},{"key":"260_CR159","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/2042098614564776","volume":"6","author":"DP Wermeling","year":"2015","unstructured":"Wermeling DP (2015) Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access. Ther Adv Drug Saf 6:20\u201331. \nhttps:\/\/doi.org\/10.1177\/2042098614564776","journal-title":"Ther Adv Drug Saf"},{"key":"260_CR160","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1124\/jpet.115.225326","volume":"354","author":"JL Wiley","year":"2015","unstructured":"Wiley JL, Marusich JA, Lefever TW, Antonazzo KR, Wallgren MT, Cortes RA, Patel PR, Grabenauer M, Moore KN, Thomas BF (2015) AB-CHMINACA, AB-PINACA, and FUBIMINA: affinity and potency of novel synthetic cannabinoids in producing delta9-tetrahydrocannabinol-like effects in mice. J Pharmacol Exp Ther 354:328\u2013339. \nhttps:\/\/doi.org\/10.1124\/jpet.115.225326","journal-title":"J Pharmacol Exp Ther"},{"key":"260_CR161","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5811\/westjem.2011.9.6866","volume":"13","author":"MP Wilson","year":"2012","unstructured":"Wilson MP, Pepper D, Currier GW, Holloman GH Jr, Feifel D (2012) The psychopharmacology of agitation: consensus statement of the american association for emergency psychiatry project Beta psychopharmacology workgroup. West J Emerg Med 13:26\u201334. \nhttps:\/\/doi.org\/10.5811\/westjem.2011.9.6866","journal-title":"West J Emerg Med"},{"key":"260_CR162","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3109\/15563650.2015.1059944","volume":"53","author":"A Wong","year":"2015","unstructured":"Wong A, Little M, Caldicott D, Easton C, Andres D, Greene SL (2015) Analytically confirmed recreational use of Phenibut (beta-phenyl-gamma-aminobutyric acid) bought over the internet. Clin Toxicol (Phila) 53:783\u2013784. \nhttps:\/\/doi.org\/10.3109\/15563650.2015.1059944","journal-title":"Clin Toxicol (Phila)"},{"key":"260_CR163","unstructured":"World Health Organization Department of Mental Health and Substance Abuse Management of Substance Abuse Team (NMH\/MSD\/MSB) Cannabis. \nhttps:\/\/www.who.int\/substance_abuse\/facts\/cannabis\/en\/\n\n. Accessed 6 June 2019"},{"key":"260_CR164","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2174\/157488906775245291","volume":"1","author":"P Yogeeswari","year":"2006","unstructured":"Yogeeswari P, Ragavendran JV, Sriram D (2006) An update on GABA analogs for CNS drug discovery. Recent Pat CNS Drug Discov 1:113\u2013118","journal-title":"Recent Pat CNS Drug Discov"},{"key":"260_CR165","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/cid\/cir005","volume":"52","author":"J Yuan","year":"2011","unstructured":"Yuan J, Inami G, Mohle-Boetani J, Vugia DJ (2011) Recurrent wound botulism among injection drug users in California. Clin Infect Dis 52:862\u2013866. \nhttps:\/\/doi.org\/10.1093\/cid\/cir005","journal-title":"Clin Infect Dis"},{"key":"260_CR166","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/ADM.0000000000000256","volume":"10","author":"H Zhu","year":"2016","unstructured":"Zhu H, Wu LT (2016) Trends and correlates of cannabis-involved emergency department visits: 2004 to 2011. J Addict Med 10:429\u2013436. \nhttps:\/\/doi.org\/10.1097\/ADM.0000000000000256","journal-title":"J Addict Med"},{"key":"260_CR167","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3390\/ijms19030833","volume":"19","author":"S Zou","year":"2018","unstructured":"Zou S, Kumar U (2018) Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system. Int J Mol Sci 19:833. \nhttps:\/\/doi.org\/10.3390\/ijms19030833","journal-title":"Int J Mol Sci"}],"container-title":["Handbook of Experimental Pharmacology","Substance Use Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2019_260","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T10:40:53Z","timestamp":1589884853000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2019_260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030336783","9783030336790"],"references-count":167,"URL":"https:\/\/doi.org\/10.1007\/164_2019_260","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"9 October 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}